Konstantinos Votanopoulos
Overview
Explore the profile of Konstantinos Votanopoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
721
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makris E, Tran T, Delitto D, Lee B, Ethun C, Grignol V, et al.
J Surg Oncol
. 2024 Apr;
129(7):1354-1363.
PMID: 38562002
Background: Undifferentiated pleomorphic sarcoma (UPS) is a relatively rare but aggressive neoplasm. We sought to utilize a multi-institutional US cohort of sarcoma patients to examine predictors of survival and recurrence...
2.
Thalji S, Ethun C, Tsai S, Clark Gamblin T, Clarke C, Bedi M, et al.
J Surg Oncol
. 2022 Dec;
127(4):550-559.
PMID: 36477427
Background: This study aimed to define how utilization of plastic surgical reconstruction (PSR) affects perioperative outcomes, locoregional recurrence-free survival (LRRFS), and overall survival (OS) after radical resection of extremity and...
3.
Spolverato G, Capelli G, Mari V, Lorenzoni G, Gregori D, Poultsides G, et al.
Ann Surg Oncol
. 2022 Aug;
29(13):8653-8661.
PMID: 36018525
Background: Recurrence after curative-intent surgery can occur in more than 50% of gastric cancer (GC) patients. We sought to identify predictors of very early recurrence (VER) among GC patients who...
4.
Gusho C, King D, Ethun C, Cardona K, Howard J, Tran T, et al.
J Surg Oncol
. 2022 Aug;
126(8):1533-1542.
PMID: 35962783
Backgrounds And Objectives: This investigation described clinicopathological features and outcomes of extraskeletal myxoid chondrosarcoma (EMC) patients. Methods: EMC patients were identified from the United States Sarcoma Collaborative database between 2000...
5.
Squires M, Ethun C, Donahue E, Benbow J, Anderson C, Jagosky M, et al.
Ann Surg Oncol
. 2022 Jan;
29(5):3291-3301.
PMID: 35015183
Background: Prognostic nomograms for patients with resected extremity soft tissue sarcoma (STS) include the Sarculator and Memorial Sloan Kettering (MSKCC) nomograms. We sought to validate these two nomograms within a...
6.
Spolverato G, Azzolina D, Paro A, Lorenzoni G, Gregori D, Poultsides G, et al.
Eur J Surg Oncol
. 2021 Dec;
48(5):1025-1032.
PMID: 34895773
Background: Accurate estimation of survival and recurrence are important to inform decisions regarding therapy and surveillance. We sought to design and validate a dynamic prognostic model for patients undergoing resection...
7.
Olson C, Suarez-Kelly L, Ethun C, Shelby R, Yu P, Hughes T, et al.
Am Surg
. 2021 Nov;
87(11):1752-1759.
PMID: 34758653
Background: Well-differentiated liposarcoma (WDLPS) is a low-grade soft tissue sarcoma with a propensity for local recurrence. The necessity of obtaining microscopically free surgical margins (R0) to minimize local recurrence is...
8.
Lee R, Ethun C, Gamboa A, Turgeon M, Tran T, Poultsides G, et al.
J Surg Oncol
. 2021 Aug;
124(8):1477-1484.
PMID: 34374088
Background: Surgical resection for sarcoma lung metastases has been associated with improved overall survival (OS). Methods: Patients who underwent curative-intent resection of sarcoma lung metastases (2000-2016) were identified from the...
9.
Squires M, Ethun C, Donahue E, Benbow J, Anderson C, Jagosky M, et al.
J Surg Oncol
. 2021 Jul;
124(5):829-837.
PMID: 34254691
Background And Objectives: Prognostic nomograms for patients undergoing resection of retroperitoneal sarcoma (RPS) include the Sarculator and Memorial Sloan Kettering (MSK) sarcoma nomograms. We sought to validate the Sarculator and...
10.
Baechle J, Marincola Smith P, Solorzano C, Tran T, Postlewait L, Maithel S, et al.
Ann Surg Oncol
. 2021 Feb;
28(11):6551-6561.
PMID: 33586069
Background: Adrenocortical carcinoma (ACC) is a rare but aggressive malignancy, and many prognostic factors that influence survival remain undefined. Individually, the GRAS (Grade, Resection status, Age, and Symptoms of hormone...